Executive Vice President, Chief Financial Officer (CFO)
At Fujisawa Pharmaceutical Co., Ltd., I was involved in work on immunosuppressant drugs related to organ transplants. I derived a lot of satisfaction seeing the data of patients who were restored to health and able to return to an active life after undergoing a transplant. Inheriting the “DNA” of Fujisawa Pharmaceutical Co., Ltd., which produced groundbreaking new drugs over a long period, Linical has grown to become a company that plays an important role as a partner of pharmaceutical companies in the process of creating and developing new drugs needed by the global community. Currently I oversee the Administrative Department of our company as CFO. For now, I will press on to contribute to the company further in the areas of finance and personnel, to enable it to grow soundly and steadily as a professional group equipped to deliver a variety of services in the field of new drug development in a way that transcends national boundaries, and the barriers of language and culture. I look forward to your continued support.